ClinicalTrials.gg
CompletedNCT07364032Updated Aug 31, 2026

Comparison Between a Mindfulness-Based Program and Standard Therapeutic Follow-Up During Pregnancy

An interventional study of Mindfulness program and Consultations in Mindfulness Protocols and Pregnancy, sponsored by Universite Cote d'Azur. Completed at 1 site in France. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Universite Cote d'Azur · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Mar 2023, registered Dec 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study aims to evaluate the effects of a 6-week mindfulness meditation program in pregnant women, compared with a psychological support control program.

Participants in the mindfulness arm will complete one instructor-led meditation session per week and five guided audio meditation sessions at home each week.

The primary objectives are to determine whether the mindfulness program leads to:

Reduced negative affect, including stress, anxiety, depression, and sleep disturbances during pregnancy.

Increased positive affect, such as mindfulness skills, self-efficacy, happiness, and life satisfaction.

Enhanced maternal-fetal attachment during pregnancy and improved maternal-infant attachment one month postpartum.

Improved mother-infant interaction quality at 3 months postpartum.

More secure infant attachment at 12 months.

Better infant outcomes, including reduced crying intensity/duration at 1 and 3 months, and improved sleep quality at 12 months.

Overall, the study evaluates whether the mindfulness program provides greater benefits than a standard parenting support intervention.

02

Conditions studied

  • Mindfulness Protocols
  • Pregnancy
03

In context

Lead sponsor

Universite Cote d'Azur is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women between 3 and 7.5 months of gestation (12-28 weeks).
  • Ability to speak and read French sufficient to understand study documents and complete questionnaires.
  • Willingness to participate in the study and to be randomized to one of the study groups.

Exclusion criteria

Exclusion Criteria:

  • Loss of the baby
  • Participation in other prenatal support programs, including prenatal yoga, haptonomy, sophrology, or mindfulness courses.
  • Severe or unstable psychiatric disorder. Inability to understand French or complete study questionnaires.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Mindfulness program

    Behavioral: Mindfulness program

  • Sham comparator
    Classical

    Other: Consultations

Interventions

  • BehavioralMindfulness program

    6 weeks of mindfulness

  • OtherConsultations

    6 week of consultation with 1 consultation per week

06

What researchers measure

Primary outcomes

  1. Anxiety

    French version of Pregnancy Related Anxiety Questionnaire (Reymond et al., 2020)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  2. Stress

    French version of Short Stress scale (Cungi et al., 2003)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  3. Depression

    French version of Edinburgh Postnatal Depression Scale, (Cox et al., 1987)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  4. Sleep disorders

    French version of The Pittsburgh sleep quality index, (Buysse et al., 1989)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  5. Mindfulness

    French version of Mindfulness Scale (Brown et Ryan., 2003)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  6. Self efficacy

    French version of Generalized Self-Efficacy scale (Schwarzer et al., 1995)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  7. Happiness

    French version of Subjective Happiness Scale (Lyubomirsky \& Lepper, 1997)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  8. Satisfaction of life

    French version of The Satisfaction with Life Scale (Diener et al., 1985)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

  9. Prenatal Attachment

    French version of Prenatal Attachment Inventory, (Muller, 1993)

    Time frame: Questionnaire will be completed at day 0 and 6 weeks later.

Secondary outcomes

  1. Cries of the baby

    French Version Colic infant questionnaire (Bellaiche et al., 2021)

    Time frame: Questionnaires will be completed daily up to 1 and 3 months post partum

  2. Sleep disturbances

    French Version Sleep disturbance scale for children, (Lecuelle et al., 2020)

    Time frame: Questionnaires will be completed at 1 year Post partum

  3. Post natal attachment

    French version of Baby Interaction Scale (Beaupuy. 2021) Pediatric Infant Parent Exam (PIPE, Fiese et al., 2001)

    Time frame: video at 1 year

07

Study locations

1 site
  • Clara Beauvois Cabinet de psychologie
    Mouans-Sartoux, 06370, France
08

References and documents

Publications

  • Beauvois C, Soubelet A. A randomized controlled trial comparing a mindfulness-based program with standard therapeutic follow-up during pregnancy: Effects on maternal mental health, infant outcomes, and mother-infant attachment. Contemp Clin Trials. 2026 Jul 8;168:108401. doi: 10.1016/j.cct.2026.108401. Online ahead of print. PubMed 42419504 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2023 to primary completion in Aug 2026, 40 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Jan 23, 2026
StartActual
Mar 31, 2023
Primary completionActual
Aug 26, 2026
CompletionActual
Aug 26, 2026
Last update
Aug 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07364032
Lead sponsor
Universite Cote d'Azur
Responsible party
Clara Beauvois (PhD Student, Universite Cote d'Azur) — Principal investigator
First posted
Jan 23, 2026
Start date
Mar 31, 2023
Primary completion
Aug 26, 2026
Completion
Aug 26, 2026
Last update
Aug 31, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion